{"id":7406,"date":"2020-06-08T15:44:30","date_gmt":"2020-06-08T22:44:30","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=7406"},"modified":"2021-03-24T15:45:12","modified_gmt":"2021-03-24T22:45:12","slug":"clinical-characteristics-of-58-children-with-a-pediatric-inflammatory-multisystem-syndrome-temporally-associated-with-sars-cov-2","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/08\/clinical-characteristics-of-58-children-with-a-pediatric-inflammatory-multisystem-syndrome-temporally-associated-with-sars-cov-2\/","title":{"rendered":"Clinical Characteristics of 58 Children\u00a0With\u00a0a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"36\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Whittaker et al. compare<\/span><span data-contrast=\"auto\">d<\/span><span data-contrast=\"auto\">\u00a0the features of\u00a0<\/span><span data-contrast=\"auto\">pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2<\/span><span data-contrast=\"auto\">\u00a0infection<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">(PIMS-TS)\u00a0<\/span><span data-contrast=\"auto\">to that of Kawasaki Disease (KD) and KD shock syndrome. Of 58 PIMS-TS patients,<\/span><span data-contrast=\"auto\">\u00a078% had evidence of current or prior SARS-CoV-2 infection. Fifty percent developed shock, 22%\u00a0<\/span><span data-contrast=\"auto\">met the definition for\u00a0<\/span><span data-contrast=\"auto\">KD<\/span><span data-contrast=\"auto\">,\u00a0<\/span><span data-contrast=\"auto\">and 14% developed coronary artery dilatation or aneurysm. Compared with\u00a0<\/span><span data-contrast=\"auto\">other cases of\u00a0<\/span><span data-contrast=\"auto\">KD and KD shock synd<\/span><span data-contrast=\"auto\">rome<\/span><span data-contrast=\"auto\">, PIMS-TS cases were older and had<\/span><span data-contrast=\"auto\">\u00a0higher<\/span><span data-contrast=\"auto\">\u00a0levels of inflammatory biomarkers.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Whittaker et al. (June 8, 2020). Clinical Characteristics of 58 Children\u00a0With\u00a0a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1001\/jama.2020.10369\"><i><span data-contrast=\"none\">https:\/\/doi.org\/10.1001\/jama.2020.10369<\/span><\/i><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Whittaker et al. compared\u00a0the features of\u00a0pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2\u00a0infection\u00a0(PIMS-TS)\u00a0to that of Kawasaki Disease (KD) and KD shock syndrome. Of 58 PIMS-TS patients,\u00a078% had evidence of current or prior SARS-CoV-2 infection. Fifty percent developed shock, 22%\u00a0met the definition for\u00a0KD,\u00a0and 14% developed coronary artery dilatation or aneurysm. Compared with\u00a0other cases of\u00a0KD and KD&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/08\/clinical-characteristics-of-58-children-with-a-pediatric-inflammatory-multisystem-syndrome-temporally-associated-with-sars-cov-2\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[20],"class_list":["post-7406","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=7406"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7406\/revisions"}],"predecessor-version":[{"id":7407,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7406\/revisions\/7407"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=7406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=7406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=7406"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=7406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}